Smith Cynthia has filed 28 insider transactions across 5 companies since June 2023.
Most recent transaction: a option exercise of 2302 shares of AGIOS PHARMACEUTICALS, INC. ($AGIO) on August 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 11, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Common stock | 2302 | $0.00 | 12,414.0000 | 74,254,956,000 | 22.77% | 0.00% |
| Aug. 11, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Restricted stock units | 2302 | $0.00 | 0.0000 | 74,254,956,000 | 100.00% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | A | Stock options (right to buy) | 15768 | $0.00 | 15,768.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Restricted stock units | 2120 | $0.00 | 0.0000 | 74,103,192,000 | 100.00% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Common stock | 2120 | $0.00 | 10,112.0000 | 74,103,192,000 | 26.53% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | A | Restricted stock units | 2816 | $0.00 | 2,816.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 12, 2025 | Spero Therapeutics, Inc. | $SPRO | Smith Cynthia | Not found | A | Common Stock | 20000 | $0.00 | 75,000.0000 | 55,900,641 | 36.36% | 0.04% |
| June 12, 2025 | Protara Therapeutics, Inc. | $PRTO | Smith Cynthia | Not found | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 40,707,937 | 9999.99% | 0.06% |
| June 10, 2025 | Akebia Therapeutics, Inc. | $AKBA | Smith Cynthia | Not found | A | Common Stock | 35700 | $0.00 | 160,933.0000 | 210,946,658 | 28.51% | 0.02% |
| June 10, 2025 | Akebia Therapeutics, Inc. | $AKBA | Smith Cynthia | Not found | A | Stock Option (Right to buy) | 53600 | $0.00 | 53,600.0000 | 210,946,658 | 9999.99% | 0.03% |
| April 17, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Smith Cynthia | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 1,524,116 | 9999.99% | 0.79% |
| Aug. 11, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Restricted stock units | 2302 | $0.00 | 2,302.0000 | 73,091,490,000 | 50.00% | 0.00% |
| Aug. 11, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Common stock | 2302 | $0.00 | 7,992.0000 | 73,091,490,000 | 40.46% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | A | Restricted stock units | 2120 | $0.00 | 2,120.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | A | Stock options (right to buy) | 11774 | $0.00 | 11,774.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Common stock | 3388 | $0.00 | 5,690.0000 | 72,967,922,000 | 147.18% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Restricted stock units | 3388 | $0.00 | 0.0000 | 72,967,922,000 | 100.00% | 0.00% |
| June 7, 2024 | Protara Therapeutics, Inc. | $PRTO | Smith Cynthia | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 11,420,948 | 9999.99% | 0.09% |
| June 6, 2024 | Akebia Therapeutics, Inc. | $AKBA | Smith Cynthia | Not found | A | Common Stock | 30000 | $0.00 | 125,233.0000 | 187,465,448 | 31.50% | 0.02% |
| June 6, 2024 | Akebia Therapeutics, Inc. | $AKBA | Smith Cynthia | Not found | A | Stock Option (Right to buy) | 45000 | $0.00 | 45,000.0000 | 187,465,448 | 9999.99% | 0.02% |
| May 29, 2024 | Spero Therapeutics, Inc. | $SPRO | Smith Cynthia | Not found | A | Common Stock | 20000 | $0.00 | 55,000.0000 | 0 | 57.14% | 0.00% |
| Oct. 5, 2023 | Spero Therapeutics, Inc. | $SPRO | Smith Cynthia | Not found | A | Common Stock | 20000 | $0.00 | 35,000.0000 | 0 | 133.33% | 0.00% |
| Aug. 11, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Common stock | 2302 | $0.00 | 2,302.0000 | 71,256,118 | 9999.99% | 0.00% |
| Aug. 11, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | M | Restricted stock units | 2302 | $0.00 | 4,604.0000 | 71,256,118 | 33.33% | 0.00% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | A | Restricted stock units | 3388 | $0.00 | 3,388.0000 | 71,256,118 | 9999.99% | 0.00% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Smith Cynthia | Director | A | Stock options (right to buy) | 18958 | $0.00 | 18,958.0000 | 71,256,118 | 9999.99% | 0.03% |
| June 6, 2023 | Akebia Therapeutics, Inc. | $AKBA | Smith Cynthia | Not found | A | Common Stock | 30000 | $0.00 | 95,233.0000 | 0 | 45.99% | 0.00% |
| June 6, 2023 | Akebia Therapeutics, Inc. | $AKBA | Smith Cynthia | Not found | A | Stock Option (Right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |